Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Sumbare Wellness review
One figure to work with — "Plans from $120/mo · confirmed after provider review" — and no breakdown by drug or dose, so there is nothing to budget against until after an intake. The claim that needs checking is the headline: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". No such trials exist. Compounded preparations are not FDA-approved and never enter registrational trials; those figures belong to studies of the branded drugs.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Sumbare Wellness at a glance
- Semaglutide
- From $120/mo, not confirmed until after provider review
- Tirzepatide
- Not priced separately on the site
- Coverage
- Not published — its own counter reads "0 states"
- Start
- Not published
How we scored Sumbare Wellness
Each factor is read off Sumbare Wellness's published pricing, disclosures and intake flow, and the six roll up into the 29/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
A single floor — "from $120/mo" — that the site itself calls an educational estimate and says is confirmed only after provider review. No breakdown by drug or dose, and no price for tirzepatide at all.
Scored low FOR NON-DISCLOSURE, and the site's own counter makes it worse: "0 states telehealth access" renders live on the homepage. Its FAQ asks the state question and the answer is missing from the served HTML.
Semaglutide carries the one published floor; tirzepatide appears only inside a sourcing footnote with no price and no program of its own. No brand-name lane and no oral form.
Scored for non-disclosure. "Cancel anytime" appears as a header claim with nothing behind it — no refund policy, no cancellation window and no notice period anywhere on the site.
Scored for non-disclosure. The process is described as a short online assessment reviewed by a licensed clinician, with follow-ups scheduled as needed, and nothing states whether a live call is required at any point.
Scored for non-disclosure. The only timing language on the site is that medication ships "on a steady, predictable cadence", which is not a number.
How we verified this review
- Last verified
- August 2026
- Confidence
- low
- Primary source
- sumbarewellness.com
Read from Sumbare Wellness's own site in August 2026. It publishes a single price — "Plans from $120/mo · confirmed after provider review" — with no breakdown by drug or dose, and no separate price for tirzepatide. Its headline "~15-20% avg. body-weight change" is attributed to clinical trials of compounded semaglutide and tirzepatide formulations; no such trials exist, and those figures come from studies of the branded drugs. Four separate stat counters render as zeros, including "0 states telehealth access" and "0.0 /5 Average care rating", and no refund or cancellation policy appears anywhere.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideStarting price, not confirmed until after review"Plans from $120 /mo · confirmed after provider review", described by the site as an "educational estimate only". | $120 | Starting price, not confirmed until after review"Plans from $120 /mo · confirmed after provider review", described by the site as an "educational estimate only". |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Sumbare Wellness's public disclosures at last review and change often; confirm the current number on Sumbare Wellness's own site.
What we like
- Names its operating entity and a mailing address
- "$0 if you're not approved", stated plainly
- The inclusive framing is substantive rather than decorative — it addresses readers previously dismissed by clinicians
- Carries the disclosure that compounded medications are not FDA-approved
The caveats
- The "~15–20% avg. body-weight change" figure is attributed to clinical trials of compounded semaglutide and tirzepatide — trials that do not exist
- One published price, "from $120/mo", confirmed only after provider review
- Tirzepatide appears in the sourcing footnote but carries no price
- Four counters render as zeros, including "0 states telehealth access" and "0.0 /5 Average care rating"
- An interactive chart presents "Week 12 Clinical Milestone -9.8%, Average reduction: -14.1 lbs" as though describing this program
- No refund or cancellation policy appears anywhere
- Its FAQ asks "What states is this service available in?" and the answer is not present in the page's HTML at all — the question renders, the answer does not
Sumbare Wellness for working moms: our verdict
One figure to work with — "Plans from $120/mo · confirmed after provider review" — and no breakdown by drug or dose, so there is nothing to budget against until after an intake. The claim that needs checking is the headline: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". No such trials exist. Compounded preparations are not FDA-approved and never enter registrational trials; those figures belong to studies of the branded drugs. It runs about $120/month — toward the affordable end of what we track.
We weigh Sumbare Wellness the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Sumbare Wellness will cost you
- Compounded semaglutide — Starting price, not confirmed until after review: $120/mo
That sits below the roughly $179 median ongoing price across the providers we track for working moms — a real cost advantage.
The medications Sumbare Wellness prescribes
Sumbare Wellness prescribes semaglutide (the active drug in Wegovy and Ozempic). These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Sumbare Wellness fits — and where it doesn't — for working moms
Right for you if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you want frictionless cancellation and no prepay lock-in — the exit terms are the weak point here.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence here is limited — Sumbare Wellness publishes little about how its program actually runs, so you're buying on price and trust in its partners. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Sumbare Wellness is a genuine value play — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Hard to specify — nothing is fixed before you submit a medical history.
Alternatives to Sumbare Wellness
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Sumbare Wellness
Head-to-head & alternatives
Sumbare Wellness, answered
- What does Sumbare Wellness cost?
- One line, unchanged when we re-read it on 2026-08-26: "Plans from $120 /mo · confirmed after provider review", and the site describes that as an educational estimate only. There is no breakdown by drug and none by dose. Tirzepatide appears in a sourcing footnote but carries no price. Alongside the figure it promises "No hidden fees, No consult charge, $0 if not approved, Cancel anytime".
- Is the 15 to 20 percent weight-loss claim sourced properly?
- No, and this is the finding that matters most. Sumbare attributes "~15–20% avg. body-weight change" to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". Those trials do not exist. Compounded preparations are not FDA-approved and never enter registrational trials; the figures belong to studies of the branded drugs. A precise-sounding citation to studies that were never run is worse than no citation.
- Which states does it serve?
- It does not say, and one of its own counters says something worse than nothing: "0 states telehealth access", one of four statistics rendering as zeros on the live page. Its FAQ then asks "What states is this service available in?" and the answer is absent from the HTML the server sends. There is no state list anywhere on the site.
- What happens to my money if I stop?
- Unpublished. "Cancel anytime" and "$0 if not approved" appear in the header, but no refund policy, cancellation window or notice period exists anywhere on the site. The decline case is covered; every case after approval is not.
- What is the chart on the homepage showing?
- Trial data, presented in a way that reads as though it describes this program. An interactive chart shows "Week 12 Clinical Milestone -9.8%, Average reduction: -14.1 lbs" with no visible separation between what published research found for branded GLP-1s and what Sumbare's own patients have experienced. Since the same page sources its headline figure to trials that do not exist, treat the chart as marketing rather than evidence.
- Who runs Sumbare Wellness?
- Sumbare Wellness LLC, named in its own footer with a mailing address at 112 N Flowers Mill Rd, Unit #465, Langhorne, PA 19047 — a unit number that reads as a mailbox rather than a clinic. Naming the entity and an address at all is more than several sites on this roster manage. We screened the entity, the brand and the domain root against the FDA warning-letter index and all three came back clean.
- Is there anything genuinely good here?
- Yes, and it is worth saying. Its inclusive framing is substantive rather than decorative — the copy speaks directly to readers who have been dismissed by clinicians before, and "Every body welcome" sits beside the practical promises rather than replacing them. It carries the correct disclosure that compounded medications are not FDA-approved, and says its medication is prepared by licensed U.S. compounding pharmacies. The problem is not the intent; it is the sourcing.
Pricing, states and verification reflect Sumbare Wellness's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.